-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JnNJYGCX3qHpLuy6DqWZBQfGTXEHy2c+DOuR2WKh9NBUglm1hbnc63Ek3C9yFVfA vPU5EYeRB1oVTExrqJXOBw== 0001104659-10-016777.txt : 20100326 0001104659-10-016777.hdr.sgml : 20100326 20100326170601 ACCESSION NUMBER: 0001104659-10-016777 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100324 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20100326 DATE AS OF CHANGE: 20100326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 10708430 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978663-3660 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP DATE OF NAME CHANGE: 20030721 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 8-K 1 a10-7083_18k.htm 8-K

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): March 24, 2010

 

BRUKER CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-30833

 

04-3110160

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

40 Manning Road
Billerica, MA 01821

(Address of principal executive offices)(Zip Code)

 

Registrant’s telephone number, including area code: (978) 663-3660

 

 

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the reporting obligation of the registrant under any of the following provisions:

 

o    Written communications pursuant to Rule 425 under the Securities Act

 

o    Soliciting material pursuant to Rule 14a-12 of the Exchange Act

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) Exchange Act

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) Exchange Act

 

 

 


 

Item 3.01.   Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On March 24, 2010, Bruker Corporation (the “Company”) notified The Nasdaq Stock Market LLC (“Nasdaq”) that Collin D’Silva, an independent director and a member of the Company’s Audit Committee, resigned from his position on the Audit Committee, effective March 9, 2010. Mr. D’Silva continues to serve as an independent director of the Company.  As a result of Mr. D’Silva’s resignation, the Audit Committee currently consists of two members and the Company is no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires the Company’s Audit Committee to consist of a minimum of three members.  In accordance with Nasdaq Listing Rule 5605(c)(4)(B), the Company has a cure period of 180 days from Mr. D’Silva’s resignation from the Audit Committee, or until September 7, 2010, to regain compliance with Nasdaq audit committee composition requirements. The Company intends to fill the vacancy on the Audit Committee as expeditiously as possible prior to the expiration of the cure period.

 

On March 25, 2010, the Company received notice from Nasdaq advising that, as result of Mr. D’Silva’s resignation from the Audit Committee, the Company was not in compliance with Nasdaq Listing Rule 5605(c)(2)(A) and confirming that the Company must regain compliance with the audit committee composition requirements by September 7, 2010.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

BRUKER CORPORATION

 

(Registrant)

 

 

Date: March 26, 2010

By:

/s/ Brian P. Monahan

 

 

Brian P. Monahan

 

 

Chief Financial Officer

 

3

 -----END PRIVACY-ENHANCED MESSAGE-----